【IPO追踪】卓正医疗启动招股，获何小鹏、明略科技加持

Core Viewpoint - The company,卓正医疗, is launching a global offering of 4.75 million new shares on the Hong Kong Stock Exchange, aiming to raise approximately HKD 219 million for various strategic initiatives [2][5]. Group 1: Offering Details - The global offering consists of 4.75 million shares, with 4.275 million shares allocated for international offering and 475,000 shares for public offering in Hong Kong [2]. - The price range for the shares is set between HKD 57.70 and HKD 66.60, with a midpoint of HKD 62.15 expected to yield a net fundraising of approximately HKD 219 million after expenses [2]. - The public offering period is from January 29 to February 3, with the final price and allocation results to be announced on February 5, and trading to commence on February 6 [2]. Group 2: Use of Proceeds - The funds raised will be allocated as follows: 35% for building a talent pool and strategic partnerships, 30% for upgrading existing facilities and opening new ones, 25% for acquiring well-performing medical institutions in first and new first-tier cities, and the remaining for working capital [2]. Group 3: Investor Support - The offering has secured support from four cornerstone investors, including Health Vision,金域医学, 明略科技, and Galaxy Dynasty, committing to subscribe for shares totaling approximately USD 1.164 million (around HKD 90.79 million) [3]. - The cornerstone investors' commitments represent about 30.44% of the total offering shares, which could increase to 32.22% if the over-allotment option is fully exercised [4]. Group 4: Company Overview - 卓正医疗 focuses on providing private medical services to affluent individuals, operating 19 medical facilities in major Chinese cities and additional clinics in Singapore and Malaysia [5]. - The company is the third-largest private high-end medical service provider in China, with a market share of 2.0% based on projected 2024 revenue [5]. - Revenue has shown significant growth, increasing from RMB 473 million in 2022 to RMB 959 million in 2024, with a compound annual growth rate of 42.3% [5].